Shanghai Keensea Medical Technology Co., Ltd. was established in January 2021. It is located in the Shanghai Jiading Industrial Zone. It is invested by the Hong Kong motherboard listed company Keensea International (HK2225) and has a registered capital of 30 million yuan. The business covers the entire industry chain of endoscopy ecology and the professional media of the industry in the industry.

The company focuses on the overall medical product solution that focuses on minimally invasive surgery, and builds a closed loop of the entire industry chain of R & D, production, sales and services. The product covers the 4K ultra -high -definition endoscope system, 3D and naked eye 3D image processing system, 4K fluorescence and multi -spectrum ultra -high -definition endoscopy system, 8K endoscope system and related auxiliary equipment.

The company has advanced automated production lines in the industry, a high -end testing center for construction, and the industry's leading light, machinery, electricity, and soft core technology. At the same time, based on the people -oriented, caring for the development of employees' quality and promotion, regularly hold various professional training, academic activities, and promotion reviews to provide employees with an elegant office environment, living facilities and career development orientation.

The company is committed to minimally invasive surgical medical and health care, insisting on making KEENSEA internationally become a strategic goal of international advanced brands, and continuously promoting the innovation and development of high -end medical equipment products and technology in China.

The company has gathered a group of experts and R & D teams with rich industry experience, as well as young technical backbones that develop high -end medical equipment products, forming a high -quality talent team with strength and ambitions Essence Keensea medical treatment opens the door to everyone with an excellent and professional ideal with a superior working environment and humanized management, providing a platform for success.

Keensea EndoPioneer is a company invested in by KEENSEA Medical Technology (02225), focusing on the development and promotion of spinal endoscopy technology. The company is committed to helping doctors in the field of spinal endoscopy master advanced skills and improve their clinical diagnostic and treatment levels through high-level academic seminars and technical training. KEENSEA Paria has advanced technology and products in the field of minimally invasive spinal surgery systems (including spinal endoscopes, instruments, and equipment hosts), and its products and systems have demonstrated excellent application results in practical operations.KEENSEA Medical Technology has achieved remarkable success in the field of high-end endoscopy and is steadily advancing into the field of percutaneous endoscopic lumbar discectomy (PELD) and minimally invasive spinal surgery to achieve diversification of products and applications. It is expected that in the future, with the progress of market education and the implementation of product registration certificates, KEENSEA Medical's PELD business will achieve breakthrough progress.